CLOZARIL

This brand name is authorized in United States. It is also authorized in Australia, Canada, Hong Kong SAR China, Ireland, Japan, Malta, New Zealand, Singapore, UK.

Active ingredients

The drug CLOZARIL contains one active pharmaceutical ingredient (API):

1	Clozapine UNII J60AR2IKIC - CLOZAPINE
	Clozapine has been shown to be an antipsychotic agent that is different from classic antipsychotics. Clozapine has potent anti-alpha-adrenergic, anticholinergic, antihistaminic, and arousal-reaction-inhibiting effects. It has also been shown to possess antiserotoninergic properties.
	Read more about Clozapine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CLOZARIL Tablet	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AH02	Clozapine	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines
Discover more medicines within N05AH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10289M, 10358E, 5628F, 5629G, 6101D, 6102E
CA	Health Products and Food Branch	00894737, 00894745, 02490668, 02490676
GB	Medicines & Healthcare Products Regulatory Agency	38307, 38309, 38311, 38322, 38326, 38327
HK	Department of Health Drug Office	45530, 45531
JP	医薬品医療機器総合機構	1179049F1021, 1179049F2028
MT	Medicines Authority	AA1187/01201, AA1187/01202
NZ	Medicines and Medical Devices Safety Authority	1578, 1580
SG	Health Sciences Authority	07234P, 07235P
US	FDA, National Drug Code	69809-0126, 69809-0127, 69809-0130, 69809-0135